ATNM
Price
$1.52
Change
+$0.06 (+4.11%)
Updated
Oct 20 closing price
Capitalization
47.42M
34 days until earnings call
Intraday Buy/Sell Signals
VYGR
Price
$5.07
Change
+$0.12 (+2.42%)
Updated
Oct 20 closing price
Capitalization
281.23M
28 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

ATNM vs VYGR

Header iconATNM vs VYGR Comparison
Open Charts ATNM vs VYGRBanner chart's image
Actinium Pharmaceuticals
Price$1.52
Change+$0.06 (+4.11%)
Volume$142.71K
Capitalization47.42M
Voyager Therapeutics
Price$5.07
Change+$0.12 (+2.42%)
Volume$635.69K
Capitalization281.23M
ATNM vs VYGR Comparison Chart in %
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATNM vs. VYGR commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATNM is a Hold and VYGR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 21, 2025
Stock price -- (ATNM: $1.52 vs. VYGR: $5.07)
Brand notoriety: ATNM and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATNM: 101% vs. VYGR: 87%
Market capitalization -- ATNM: $47.42M vs. VYGR: $281.23M
ATNM [@Biotechnology] is valued at $47.42M. VYGR’s [@Biotechnology] market capitalization is $281.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATNM’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • ATNM’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than ATNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATNM’s TA Score shows that 4 TA indicator(s) are bullish while VYGR’s TA Score has 4 bullish TA indicator(s).

  • ATNM’s TA Score: 4 bullish, 5 bearish.
  • VYGR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ATNM and VYGR are a bad buy in the short-term.

Price Growth

ATNM (@Biotechnology) experienced а -5.59% price change this week, while VYGR (@Biotechnology) price change was +3.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.62%. For the same industry, the average monthly price growth was +17.01%, and the average quarterly price growth was +69.82%.

Reported Earning Dates

ATNM is expected to report earnings on Nov 24, 2025.

VYGR is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+3.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VYGR($281M) has a higher market cap than ATNM($47.4M). ATNM YTD gains are higher at: 20.635 vs. VYGR (-10.582). ATNM has higher annual earnings (EBITDA): -43.43M vs. VYGR (-119.18M). ATNM has more cash in the bank: 59.9M vs. VYGR (43.9M). ATNM has less debt than VYGR: ATNM (1.29M) vs VYGR (40.2M). VYGR has higher revenues than ATNM: VYGR (42.6M) vs ATNM (0).
ATNMVYGRATNM / VYGR
Capitalization47.4M281M17%
EBITDA-43.43M-119.18M36%
Gain YTD20.635-10.582-195%
P/E RatioN/A6.00-
Revenue042.6M-
Total Cash59.9M43.9M136%
Total Debt1.29M40.2M3%
FUNDAMENTALS RATINGS
ATNM vs VYGR: Fundamental Ratings
ATNM
VYGR
OUTLOOK RATING
1..100
5875
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
44
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9997
PRICE GROWTH RATING
1..100
6241
P/E GROWTH RATING
1..100
1008
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VYGR's Valuation (44) in the Biotechnology industry is in the same range as ATNM (63). This means that VYGR’s stock grew similarly to ATNM’s over the last 12 months.

VYGR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ATNM (100). This means that VYGR’s stock grew similarly to ATNM’s over the last 12 months.

VYGR's SMR Rating (97) in the Biotechnology industry is in the same range as ATNM (99). This means that VYGR’s stock grew similarly to ATNM’s over the last 12 months.

VYGR's Price Growth Rating (41) in the Biotechnology industry is in the same range as ATNM (62). This means that VYGR’s stock grew similarly to ATNM’s over the last 12 months.

VYGR's P/E Growth Rating (8) in the Biotechnology industry is significantly better than the same rating for ATNM (100). This means that VYGR’s stock grew significantly faster than ATNM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATNMVYGR
RSI
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 22 days ago
72%
Bullish Trend 6 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 8 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
87%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ESTA49.312.05
+4.34%
Establishment Labs Holdings
TPST10.530.39
+3.85%
Tempest Therapeutics Inc
SANM132.673.42
+2.65%
Sanmina Corp
PANL4.860.05
+1.04%
Pangaea Logistics Solutions Ltd
JNJ193.720.50
+0.26%
Johnson & Johnson

ATNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATNM has been loosely correlated with CRBU. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNM jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATNM
1D Price
Change %
ATNM100%
+4.11%
CRBU - ATNM
44%
Loosely correlated
+7.22%
IPSC - ATNM
43%
Loosely correlated
+5.20%
RXRX - ATNM
42%
Loosely correlated
+13.99%
ACHV - ATNM
39%
Loosely correlated
+19.05%
PRLD - ATNM
38%
Loosely correlated
+8.40%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
+2.42%
RGNX - VYGR
53%
Loosely correlated
+7.76%
KYMR - VYGR
51%
Loosely correlated
+1.12%
IMNM - VYGR
48%
Loosely correlated
+3.70%
IMTX - VYGR
47%
Loosely correlated
+11.04%
XENE - VYGR
46%
Loosely correlated
+4.35%
More